Publications Office of the EU
COVID-19 vaccine distribution – BioNTech/Pfizer Comirnaty for the next period - EU tenders
DisplayCustomHeader
Procurement Detail Actions Portlet
OP Portal - Procurement - Details

This page contains content generated automatically to improve findability and accessibility

- indicates CPV codes deduced from the text of the procedure

- indicates text translated automatically in your browsing language

COVID-19 vaccine distribution – BioNTech/Pfizer Comirnaty for the next period Text automatically translated in your browsing language Automatically translated

  • Published
    07/05/2025
  • Deadline
    09/06/2025
  • Today
    19/06/2025
Status
Submission closed
Type of contract
Services
Subject for Renewal
No
Buyer
VŠEOBECNÁ ZDRAVOTNÍ POJIŠŤOVNA ČESKÉ REPUBLIKY
Place of performance
NUTS code: Multiple place of performance
Location of buyer
NUTS code: CZ010 Hlavní město Praha
Business sector (Main CPV)
64120000 Courier services
Total estimated contract value (excluding VAT)
Not available
Total final contract value (excluding VAT)
Not available
Number of lots
2
Tender reference number
2500423
Description

The purpose of this public contract is to ensure the storage and distribution of medicinal products named Comirnaty manufactured by BioNTech/Pfizer (“Comirnaty vaccines”) containing the SARS-CoV-2 COVID-19 vaccine, which will be procured from state budget funds into the ownership of the Czech Republic on the basis of Commission Decision C(2020) 4192 of 18 June 2020 approving the agreement with the Member States on the acquisition of COVID-19 vaccines on behalf of the Member States and related procedures or otherwise in accordance with the legislation, and which will be delivered by the manufacturer or importer to the Czech Republic in the second half of 2025 and in 2026. At the time the tender procedure is launched, it is not known to the contracting authorities, for objective reasons, in which specific packaging (or combination of packagings) the predominant quantity of Comirnaty vaccine will be delivered to the Czech Republic, stored and distributed by the selected supplier, while Comirnaty vaccine requires, according to the conditions set by the manufacturer, loading and storage in a different temperature (cold) regime, which also involves different material and technical equipment of the supplier. The contracting authorities are only aware that the Comirnaty vaccine intended for vaccination of children under 12 years of age will be supplied in multidose vials (MDVs) that require storage at a temperature regimen of -90 to -600 C, but the quantity of vaccine for children under 12 years of age makes up a completely minor share of the total estimated quantity of vaccine to be distributed and thus does not require specific material and technical equipment of the supplier on a larger scale. For these reasons, in accordance with Section 35 of the PPA, the public contract is divided into lots (Part A and Part B). The tender will result in the conclusion of two Framework Agreements (Framework Agreements for Part A and Framework Agreements for Part B), whereby the distribution of Comirnaty vaccine will always be provided under only one Framework Agreement, depending on the specific predominant type of packaging and the temperature regime in which the vaccines will be delivered to the Czech Republic for the given vaccination season. The Ministry of Health of the Czech Republic (hereinafter referred to as the “Ministry of Health of the Czech Republic”) shall notify contracting entities and selected suppliers within 5 working days of the effective date of each framework agreement (for Part A and Part B) or at least two months before the date of commencement of distribution under the relevant framework agreement of the type of packaging and temperature regime in which the vaccines will be delivered in the predominant quantity in the territory of the Czech Republic, and in connection with whether distribution will take place under the Framework Agreement for Part A or under the Framework Agreement for Part B. In the event of a change in the predominant type of packaging of Comirnaty vaccine to be stored and distributed in the territory of the Czech Republic, during the effective date of the framework agreements, the Ministry of Health of the Czech Republic shall notify contracting entities and selected suppliers of this fact no later than 2 months before the start of distribution of the vaccine in a different type of packaging and at the same time shall notify the end of distribution of the vaccine in the previous type of packaging. Text automatically translated in your browsing language Automatically translated

Submission Method
Electronic via:
https://tenderarena.cz/dodavatel/zakazka/791625
Tenders may be submitted
Electronic submission: required
https://tenderarena.cz/dodavatel/zakazka/791625
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
The procurement involves the establishment of a framework agreement
Conditions for opening tenders (date)
Not available
Buyers
Česká průmyslová zdravotní pojišťovna
Zdravotní pojišťovna ministerstva vnitra České republiky
Zaměstnanecká pojišťovna Škoda
Oborová zdravotní pojišťovna zaměstnanců bank, pojišťoven a stavebnictví
RBP, zdravotní pojišťovna
Vojenská zdravotní pojišťovna České republiky
Place of performance
CPV code

64120000 - Courier services

33600000 - Pharmaceutical products CVP code deduced from the text of the procedure AI-generated

63100000 - Cargo handling and storage services CVP code deduced from the text of the procedure AI-generated

33000000 - Medical equipments, pharmaceuticals and personal care products CVP code deduced from the text of the procedure AI-generated

63000000 - Supporting and auxiliary transport services; travel agencies services CVP code deduced from the text of the procedure AI-generated

33651000 - General anti-infectives for systemic use and vaccines CVP code deduced from the text of the procedure AI-generated

63120000 - Storage and warehousing services CVP code deduced from the text of the procedure AI-generated

33650000 - General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents CVP code deduced from the text of the procedure AI-generated

Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.